Drug Shortage Report for BENZACLIN

Last updated on 2023-03-23 History
Report ID 179119
Drug Identification Number 02248472
Brand name BENZACLIN
Common or Proper name BENZACLIN
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) BENZOYL PEROXIDE CLINDAMYCIN
Strength(s) 5% 1%
Dosage form(s) GEL
Route of administration TOPICAL TOPICAL
Packaging size n/a
ATC code D10AF
ATC description ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-03-12
Actual start date
Estimated end date 2023-03-30
Actual end date 2023-03-11
Shortage status Avoided shortage
Updated date 2023-03-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-03-23 French Compare
v4 2023-03-23 English Compare
v3 2023-03-13 English Compare
v2 2022-12-21 French Compare
v1 2022-12-21 English Compare

Showing 1 to 5 of 5